Libaccord

Supercooled Liquid Nitrogen for Treatment of Arrhythmia

Active Pre-Funding Startup Haifa Founded 2020-03

Libaccord is the developer of an innovative device for treating ventricular and atrial arrhythmias using super-cooled liquid nitrogen. Based on the deepest possible ablation (transmural), the companys solution uses the novel clinical approach of scar homogenization to reduce procedure time and includes built-in ablation depth feedback to ensure performance…

SectorHealth Tech & Life Sciences
StagePre-Funding
Employees2
Founded2020-03
HQHaifa
Patents1
Confidence95
Sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Target customers
Healthcare & Life SciencesHealthcareProviders